NF-kB upregulates YKL-40 in glioma cells [188], suggesting that the impacts of variations in the gut microbiome and gut permeability may significantly upregulate NF-kB in CNS cells, which would be potentiated by GBH. The gene discussed is NFKB1; the disease is central nervous system cancer.